Dara Wright
CEO, Madison Medical
Dara Wright is a biotechnology veteran known for building high-performing teams with a focus on innovation and operational excellence. Most recently, Ms. Wright served as the Executive Vice President and President of Clinical Diagnostics Group at Bio-Rad Laboratories (NYSE: BIO). There she led a global business comprised of a broad product portfolio including instrumentation, tests, and software for diabetes, blood typing, infectious disease, immunology, autoimmunity and quality controls serving clinical hospital laboratories, reference laboratories, and academic medical centers. During her tenure, she grew the business to $1.5 billion in revenue.
She previously served as the Vice President and General Manager for the Protein and Cell Analysis Business Unit of Thermo Fisher Scientific from 2016 to 2020, where she managed a $1 billion P&L and over 800 associates. Prior to Thermo Fisher Scientific, she held various senior leadership roles at Affymetrix, Boreal Genomics and Becton Dickinson.
Ms. Wright has served as a board member of Madison’s Filtration Group since June 2022. She earned a Bachelor of Arts in Biology and Spanish from Willamette University and an MBA from San Diego State University.